Username Password
S&P 500: 1,351.68 Change: +0.14%

SHIRE PLC ADS (SHPGY)

Overview
Price 103.60
Price Change Today 0.00 (0.00%)
P&P rating Rating: 0
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $103.60
Daily Range $0.00 - $0.00
52-Week Range $79.02 - $105.53
Volume 0
chart
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
Other Resources for SHPGY
zacks.com
Commentary
Zacks Blog: Shire and Sangamo Cut a Deal
February 7, 2012
Zacks Blog: Reasons To Stay Interested in SNWV
January 25, 2012
Zacks Blog: Sanofi Gets Nod for Framingham Unit
January 20, 2012
Zacks Blog: Shire, Prasco Ink Deal
January 16, 2012
Zacks Blog: Shire Acquires US Rights to Resolor
January 12, 2012
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
 
Brokerage Analyst Recommendations
16 Brokerage Firms Covering SHPGY
 
  
Strong Buy
10
Buy
0
Hold
6
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.75
 
SHPGY Ratings:BUY  SELL  HOLD
SHPGY Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

3 Buy
0 Sell
 
Top Buy Analysis
BUY: SHPGY Rating: 0
Company: SHIRE PLC - AMERICAN DEPOSITARY SHAR
Points: -1.73
Start Price: $100.74
Start Date: 01/11/2012 10:13 PM
wdg1R1
wdg1R1
P&P Score: 0.00
Recs:
With 2 new indications for Vyvanse coming in the near future, current profits for Vyvanse and Intuniv ahead of predicted gains, and the advancement of the biopharma industry within healthcare, BUY it. This stock has a 72/105 range and is only going up. Plan to possibly sell but not within the next 3 years.

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 02/07/12 Shire and Sangamo Cut a Deal - Analyst Blog 0
Zacks_Analysts
0.00 01/25/12 Reasons To Stay Interested in SNWV - Analyst Blog 0
Zacks_Analysts
0.00 01/25/12 Reasons To Stay Interested in SNWV - Analyst Blog 0
Zacks_Analysts
0.00 01/20/12 Sanofi Gets Nod for Framingham Unit - Analyst Blog 0
Zacks_Analysts
0.00 01/16/12 Shire, Prasco Ink Deal - Analyst Blog 0
Zacks_Analysts
0.00 01/12/12 Shire Acquires US Rights to Resolor - Analyst Blog 0
Zacks_Analysts
0.00 01/09/12 Shire's ADHD Drug Up for Review - Analyst Blog 0
Zacks_Analysts
0.00 12/13/11 Shire Reports Positive Data - Analyst Blog 0
Zacks_Analysts
0.00 08/26/11 Shire's Firazyr Cleared in the US - Analyst Blog 0
Zacks_Analysts
0.00 08/25/11 Setback for Shire - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   6   7   8  >>
Commentary
BUY: SHIRE PLC - AMERICAN DEPOSITARY SHAR (SHPGY)
Start Price: $100.74
Points: -1.73
Created: 01/11/2012
With 2 new indications for Vyvanse coming in the near future, current profits for Vyvanse and Intuniv ahead of predicted gains, and the advancement of the biopharma industry within healthcare, BUY it. This stock has a 72/105 range and is only going up. Plan to possibly sell but not within the next 3 years.

Comments: 0 | Comment

Recs:
 
BUY: SHIRE PLC - AMERICAN DEPOSITARY SHAR (SHPGY)
Start Price: $97.13
Points: -1.43
Created: 11/06/2011

Comments: 0 | Comment

vip vip
Recs:
 
BUY: SHIRE PLC - AMERICAN DEPOSITARY SHAR (SHPGY)
Start Price: $55.55
Points: +94.01
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
wdg1R1 BUY Week or Less 01/11/2012 $100.74 $103.37
(+0.08%)
+2.61% +4.34% -1.73 view
vip 99.98 BUY One to Three Months 11/06/2011 $97.13 $103.37
(+0.08%)
+6.42% +7.86% -1.43
DrewPeazy 78.81 BUY Six Months to a Year 01/01/2008 $55.55 $103.37
(+0.08%)
+86.08% -7.92% +94.01
Sponsored Links